Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 20,000 shares at $15.47 ($309K) on 2021-09-07, disclosed to the SEC on 2021-09-09.
Seasonal sale ($309k) by President & CEO — this insider has traded CARA in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |
| CARA | SELL | 2020-12-29 | $80K | — | Filing → |